Buscar
-
Comprendre la défiance à l'égard de l'évaluation des risques médicamenteux. Au-delà des conflits d'intérêts
(Thérapie. vol. 73, n° 4, pp. 341-348, 2018-09)Article de revue -
Faut-il limiter la durée des traitements par benzodiazepines ?
(Presse medicale (Paris, France. vol. 47, n° 10, pp. 892-898, 2018-10)Article de revue -
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
(The Lancet Oncology. vol. 19, n° 12, pp. 1579-1589, 2018-12)Article de revue -
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis
(British Journal of Clinical Pharmacology, 2021-03-13)Article de revue -
Risk of Intracranial Aneurysm and Dissection and Fluoroquinolone Use: A Case-Time-Control Study
(Stroke. vol. 51, n° 3, pp. 994-997, 2020)Article de revue -
Methods in pharmacoepidemiology
(Thérapie. vol. 74, n° 2, pp. 187-197, 2019-04)Article de revue -
Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
(Therapies, 2023-03-15)Article de revue -
The ongoing structuring of human papillomavirus (HPV) vaccination in middle schools in Nouvelle-Aquitaine, France
(Infectious Diseases Now. vol. 53, n° 5, pp. 104717, 2023-05-04)Article de revue -
Usages et mesusages de benzodiazepines hors France
(Presse medicale (Paris, France. vol. 47, n° 10, pp. 882-885, 2018-10)Article de revue -
Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
(CNS Drugs. n° 32, pp. 673-684, 2018)Article de revueLibre acceso